Fabtech Technologies Cleanrooms Ltd

Fabtech Technologies Cleanrooms Ltd

₹ 344 -2.13%
12 Jun - close price
About

Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]

Key Points

Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.

  • Market Cap 424 Cr.
  • Current Price 344
  • High / Low 357 / 162
  • Stock P/E 35.2
  • Book Value 75.6
  • Dividend Yield 0.58 %
  • ROCE 21.5 %
  • ROE 16.6 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 25.1% CAGR over last 5 years

Cons

  • Promoter holding has decreased over last quarter: -24.7%
  • The company has delivered a poor sales growth of 10.2% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2024 Mar 2025
48 81
42 73
Operating Profit 6 8
OPM % 12% 10%
0 1
Interest 0 0
Depreciation 0 0
Profit before tax 5 9
Tax % 33% 21%
4 7
EPS in Rs 12.71 5.43
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
86 65 107 114 83 139
80 64 101 101 75 124
Operating Profit 6 1 6 12 8 16
OPM % 7% 2% 5% 11% 10% 11%
1 0 0 0 1 1
Interest 1 0 1 1 1 0
Depreciation 0 1 0 0 0 0
Profit before tax 6 0 5 11 7 16
Tax % 29% -52% 35% 28% 28% 24%
4 1 3 8 5 12
EPS in Rs 1,310.00 233.33 11.49 29.07 18.88 9.77
Dividend Payout % 0% 0% 0% 0% 0% 20%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 9%
TTM: 69%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 56%
TTM: 129%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 16%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 3 3 12
Reserves 32 32 35 44 49 81
10 7 8 6 5 0
21 25 32 23 24 24
Total Liabilities 66 67 79 75 81 117
3 3 3 3 4 3
CWIP 0 0 0 0 0 0
Investments 3 3 3 3 4 28
60 60 72 69 73 86
Total Assets 66 67 79 75 81 117

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-9 4 3 8 4 2
2 -1 -4 -3 -2 -25
7 -3 1 -4 -2 24
Net Cash Flow 1 -1 0 1 0 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 188 236 172 149 203 132
Inventory Days 54 85 52 45 82 58
Days Payable 108 139 96 69 105 67
Cash Conversion Cycle 134 183 127 124 179 123
Working Capital Days 158 189 122 119 172 183
ROCE % 2% 13% 25% 15% 22%

Shareholding Pattern

Numbers in percentages

Mar 2025
68.41%
0.69%
11.24%
19.66%
No. of Shareholders 349

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents